OIM
DSCI

Oracle Investment Management’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Oracle Investment Management’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-326,844
Closed -$2.72M – 31
2014
Q3 		$2.72M Sell
326,844
-165,952
-34% -$1.54M 0.38% 23
2014
Q2 		$5.7M Sell
492,796
-7,204
-1% -$73.9K 0.69% 23
2014
Q1 		$6.34M Buy
+500,000
New +$6.46M 0.72% 22

Other funds holding DSCI

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Oracle Investment Management's DSCI Position: Q4 2014 in Review

Oracle Investment Management sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q4 2014, closing a stake of 326,844 shares — an estimated $2.72M sold.

Oracle Investment Management first reported a position in DSCI in Q1 2014 and held it in 3 quarters. The position peaked at $6.34M in Q1 2014. 63 funds tracked by Wall St. Rank hold DSCI as of Q4 2014.

  • Oracle Investment Management reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q4 2014 after selling out during the quarter.
  • Oracle Investment Management sold 326,844 Derma Sciences, Inc. Common Stock (DE) shares in Q4 2014, an estimated $2.72M.
  • Oracle Investment Management first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q1 2014 and held it in 3 quarters.
  • Oracle Investment Management's Derma Sciences, Inc. Common Stock (DE) position peaked at $6.34M in Q1 2014.
  • 63 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q4 2014.

Based on Oracle Investment Management's 13F filing for Q4 2014, filed 17 Feb 2015.